Literature DB >> 23574338

Crowd-funded micro-grants for genomics and "big data": an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy.

Vural Özdemir1, Kamal F Badr, Edward S Dove, Laszlo Endrenyi, Christy Jo Geraci, Peter J Hotez, Djims Milius, Maria Neves-Pereira, Tikki Pang, Charles N Rotimi, Ramzi Sabra, Christineh N Sarkissian, Sanjeeva Srivastava, Hesther Tims, Nathalie K Zgheib, Ilona Kickbusch.   

Abstract

Biomedical science in the 21(st) century is embedded in, and draws from, a digital commons and "Big Data" created by high-throughput Omics technologies such as genomics. Classic Edisonian metaphors of science and scientists (i.e., "the lone genius" or other narrow definitions of expertise) are ill equipped to harness the vast promises of the 21(st) century digital commons. Moreover, in medicine and life sciences, experts often under-appreciate the important contributions made by citizen scholars and lead users of innovations to design innovative products and co-create new knowledge. We believe there are a large number of users waiting to be mobilized so as to engage with Big Data as citizen scientists-only if some funding were available. Yet many of these scholars may not meet the meta-criteria used to judge expertise, such as a track record in obtaining large research grants or a traditional academic curriculum vitae. This innovation research article describes a novel idea and action framework: micro-grants, each worth $1000, for genomics and Big Data. Though a relatively small amount at first glance, this far exceeds the annual income of the "bottom one billion"-the 1.4 billion people living below the extreme poverty level defined by the World Bank ($1.25/day). We describe two types of micro-grants. Type 1 micro-grants can be awarded through established funding agencies and philanthropies that create micro-granting programs to fund a broad and highly diverse array of small artisan labs and citizen scholars to connect genomics and Big Data with new models of discovery such as open user innovation. Type 2 micro-grants can be funded by existing or new science observatories and citizen think tanks through crowd-funding mechanisms described herein. Type 2 micro-grants would also facilitate global health diplomacy by co-creating crowd-funded micro-granting programs across nation-states in regions facing political and financial instability, while sharing similar disease burdens, therapeutics, and diagnostic needs. We report the creation of ten Type 2 micro-grants for citizen science and artisan labs to be administered by the nonprofit Data-Enabled Life Sciences Alliance International (DELSA Global, Seattle). Our hope is that these micro-grants will spur novel forms of disruptive innovation and genomics translation by artisan scientists and citizen scholars alike. We conclude with a neglected voice from the global health frontlines, the American University of Iraq in Sulaimani, and suggest that many similar global regions are now poised for micro-grant enabled collective innovation to harness the 21(st) century digital commons.

Entities:  

Mesh:

Year:  2013        PMID: 23574338      PMCID: PMC4702427          DOI: 10.1089/omi.2013.0034

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  39 in total

1.  Global + local = glocal public health.

Authors:  I Kickbusch
Journal:  J Epidemiol Community Health       Date:  1999-08       Impact factor: 3.710

2.  Algorithm discovery by protein folding game players.

Authors:  Firas Khatib; Seth Cooper; Michael D Tyka; Kefan Xu; Ilya Makedon; Zoran Popovic; David Baker; Foldit Players
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  What to do when the risk environment is rapidly shifting and heterogeneous? Anticipatory governance and real-time assessment of social risks in multiply marginalized populations can prevent IRB mission creep, ethical inflation or underestimation of risks.

Authors:  Vural Ozdemir
Journal:  Am J Bioeth       Date:  2009-11       Impact factor: 11.229

4.  Research funding: Global challenges need global solutions.

Authors:  Subra Suresh
Journal:  Nature       Date:  2012-10-18       Impact factor: 49.962

5.  Collective theranostics and postgenomics entrepreneurship: rethinking innovations as knowledge ecosystems built by complex collaboration.

Authors:  Samer A Faraj; Eugene Kolker; Lisa Bevilacqua; Vural Özdemir
Journal:  Expert Rev Mol Diagn       Date:  2012-11       Impact factor: 5.225

6.  Direct-to-consumer theranostics, 21st century collective innovation and entrepreneurship. Interview by Barbara Prainsack.

Authors:  Vural Özdemir; Edward S Dove
Journal:  Expert Rev Mol Diagn       Date:  2012-11       Impact factor: 5.225

7.  OMICS 2.0: a practice turn for 21(st) century science and society.

Authors:  Vural Özdemir
Journal:  OMICS       Date:  2013-01

8.  A delicate web: household changes in health behaviour enabled by microcredit in Burkina Faso.

Authors:  Monique Hennink; Deborah A McFarland
Journal:  Glob Public Health       Date:  2013-01-18

9.  Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.

Authors:  Edward S Dove; Samer A Faraj; Eugene Kolker; Vural Ozdemir
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

10.  The arrival of genomic medicine to the clinic is only the beginning of the journey.

Authors:  James P Evans; Muin J Khoury
Journal:  Genet Med       Date:  2013-01-10       Impact factor: 8.822

View more
  9 in total

1.  Participation in global value chain and green technology progress: evidence from big data of Chinese enterprises.

Authors:  Malin Song; Shuhong Wang
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-28       Impact factor: 4.223

Review 2.  Toward a Literature-Driven Definition of Big Data in Healthcare.

Authors:  Emilie Baro; Samuel Degoul; Régis Beuscart; Emmanuel Chazard
Journal:  Biomed Res Int       Date:  2015-06-02       Impact factor: 3.411

Review 3.  From big data analysis to personalized medicine for all: challenges and opportunities.

Authors:  Akram Alyass; Michelle Turcotte; David Meyre
Journal:  BMC Med Genomics       Date:  2015-06-27       Impact factor: 3.063

4.  The emergence of commercial genomics: analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004.

Authors:  Ilse R Wiechers; Noah C Perin; Robert Cook-Deegan
Journal:  Genome Med       Date:  2013-09-20       Impact factor: 11.117

5.  Citizen science to further precision medicine: from vision to implementation.

Authors:  Carolyn Petersen; Robin R Austin; Uba Backonja; Hugo Campos; Arlene E Chung; Eric B Hekler; Pei-Yun S Hsueh; Katherine K Kim; Anthony Pho; Liz Salmi; Anthony Solomonides; Rupa S Valdez
Journal:  JAMIA Open       Date:  2019-12-03

6.  The grant is dead, long live the data - migration as a pragmatic exit strategy for research data preservation.

Authors:  Tomasz Zielinski; Johnny Hay; Andrew J Millar
Journal:  Wellcome Open Res       Date:  2019-09-23

7.  Evolutionary genomics can improve prediction of species' responses to climate change.

Authors:  Ann-Marie Waldvogel; Barbara Feldmeyer; Gregor Rolshausen; Moises Exposito-Alonso; Christian Rellstab; Robert Kofler; Thomas Mock; Karl Schmid; Imke Schmitt; Thomas Bataillon; Outi Savolainen; Alan Bergland; Thomas Flatt; Frederic Guillaume; Markus Pfenninger
Journal:  Evol Lett       Date:  2020-01-14

8.  Creative Approaches to Global Cancer Research and Control.

Authors:  Anne F Rositch; Christopher Loffredo; Maria T Bourlon; Paul C Pearlman; Clement Adebamowo
Journal:  JCO Glob Oncol       Date:  2020-07

9.  What Role for Law, Human Rights, and Bioethics in an Age of Big Data, Consortia Science, and Consortia Ethics? The Importance of Trustworthiness.

Authors:  Edward S Dove; Vural Özdemir
Journal:  Laws       Date:  2015-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.